Detalles de la búsqueda
1.
Chidamide plus Tyrosine Kinase Inhibitor Remodel the Tumor Immune Microenvironment and Reduce Tumor Progression When Combined with Immune Checkpoint Inhibitor in Naïve and Anti-PD-1 Resistant CT26-Bearing Mice.
Int J Mol Sci
; 23(18)2022 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36142591
2.
CC-01 (chidamide plus celecoxib) modifies the tumor immune microenvironment and reduces tumor progression combined with immune checkpoint inhibitor.
Sci Rep
; 12(1): 1100, 2022 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35058524
Resultados
1 -
2
de 2
1
Próxima >
>>